Akèy › Leksemi mieloïd egi › Kalifòni › Baldwin Park
Etid klinik pou Leksemi mieloïd egi nan Baldwin Park, CA
40 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote Baldwin Park (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Ap rekriteFaz 2/3
- City of Hope National Medical Center /ID# 279568, Duarte · 4 mi lwen
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Ap rekriteFaz 3
- City of Hope, Duarte · 4 mi lwen
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Ap rekriteFaz 3
- Clinical Trial Site, Duarte · 4 mi lwen
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Ap rekriteFaz 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Ap rekriteFaz 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Ap rekriteFaz 1
- City of Hope National Medical Center, Duarte · 4 mi lwen
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Ap rekriteFaz 1/2Volontè an sante akeyi
- City of Hope, Duarte · 4 mi lwen
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Ap rekriteFaz 1/2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi lwen
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Ap rekriteFaz 1/2
- City of Hope National Medical Center, Duarte · 4 mi lwen
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
Individualized AML Treatment
Ap rekriteEtid obsèvasyon
- City of Hope Medical Center, Duarte · 4 mi lwen
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Ap rekriteFaz 2
- City of Hope Medical Center, Duarte · 4 mi lwen
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Ap rekriteFaz 1Volontè an sante akeyi
- City of Hope Medical Center, Duarte · 4 mi lwen
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Ap rekriteFaz 3
- City of Hope Comprehensive Cancer Center - Duarte, Duarte · 4 mi lwen
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- City of Hope, Duarte · 4 mi lwen
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Ap rekriteFaz 2
- City of Hope Medical Center, Duarte · 4 mi lwen
A Study of Revumenib and Mezigdomide in People With Leukemia
Ap rekriteFaz 1/2
- City of Hope Cancer Center (Data collection only), Duarte · 4 mi lwen
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Ap rekriteFaz 1Volontè an sante akeyi
- City of Hope Medical Center, Duarte · 4 mi lwen
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Ap rekriteFaz 2
- City of Hope, Duarte · 4 mi lwen
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Ap rekriteFaz 2Volontè an sante akeyi
- City of Hope Medical Center, Duarte · 4 mi lwen
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Ap rekriteFaz 1
- City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mi lwen
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Ap rekriteFaz 2
- City of Hope Medical Center, Duarte · 4 mi lwen
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- City of Hope - Duarte, Duarte · 4 mi lwen
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Ap rekriteFaz 1
- City of Hope Medical Center, Duarte · 4 mi lwen
Study of REM-422 in Patients With AML or Higher Risk MDS
Ap rekriteFaz 1
- City of Hope, Duarte · 4 mi lwen
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Ap rekriteFaz 1
- City of Hope National Medical Center, Duarte · 4 mi lwen
Etid Leksemi mieloïd egi nan lòt vil
- Houston, TX85 etid
- New York City, NY51 etid
- Boston, MA44 etid
- Seattle, WA40 etid
- Columbus, OH35 etid
- Philadelphia, PA34 etid
- Durham, NC33 etid
- Atlanta, GA30 etid
- Tampa, FL29 etid
- Chicago, IL26 etid
- Portland, OR25 etid
- Miami, FL24 etid
Lòt etid nan Baldwin Park
- Kansè nan tete45 etid
- Kansè kolorektal38 etid
- Kansè Poumon ki pa ti selil36 etid
- Kansè (tout kalite)33 etid
- Kansè pwostat30 etid
- Kansè Metastatik30 etid
- Sendwòm myelodisplastik26 etid
- Kansè ovè25 etid
- Kansè poumon24 etid
- Myelom Miltip23 etid
- Kansè lestomak22 etid
- Leksemi limfoblastik egi21 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.